Presenting: Innovations in rTMS Treatment
You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series:
Innovations in rTMS Treatment
1. Learners will be able to identify conventional rTMS strategies to treat medication resistance depression.
2. Learners will be able to identify novel brain mechanisms that may help to identify treatment resistant depression.
3. Learners will be able to identify novel rTMS treatment strategies to treat depression when conventional approaches do not work.
Date & Time: Tuesday, June 4, 2019 | 5:00 PM (PDT) - 6:00 PM (PDT)
Cost: Members: $25 | Non-members $50 | Student Members FREE
Speakers: Dr. Jeff Daskalakis, MD
Jeff Daskalakis is a Professor of Psychiatry at University of Toronto. He is presently the Temerty Chair in Therapeutic Brain Intervention and chief of the General Adult Psychiatry and Health Systems Division at CAMH. The Temerty Centre uses magnetic brain stimulation to study the role of cortical inhibition and plasticity as potential pathophysiological mechanisms in schizophrenia, depression and obsessive compulsive disorder. Dr. Daskalakis also conducts treatment studies using repetitive transcranial magnetic brain stimulation (rTMS) and magnetic seizure therapy (MST) for refractory symptoms in these disorders. He holds or has held NARSAD, CIHR, Brain Canada and NIMH operating awards and grants. He has also been awarded the Samarthji Lal Award in Mental Health Research from the Graham Boeckh Foundation. He is also a member of the Brain and Behavior Research Foundation Scientific Council. Finally, he has over 320 peer-reviewed publications and is an editorial board member for Biological Psychiatry and an Associate Editor for Clinical Neurophysiology.
|Grand Rounds Webinar|
|Clinical TMS Society Member||$ 25.00|
Grand Rounds Webinar